Aunque la semaglutida y la tirzepatida - respectivamente los nombres genricos del frmaco activo de Wegovy, Ozempic, Mounjaro y Zepbound - dominan el mercado de los medicamentos para adelgazar (Mounjaro y Ozempic slo estn autorizados para la diabetes), ni Novo Nordisk ni Eli Lilly se duermen en los laureles
Discontinue use if irritation, redness or allergic reactions occur
The dose is gradually increased over 1620 weeks (starting at 0.25 mg and increasing through 0.5 mg, 1.0 mg, and 1.7 mg to the maintenance dose of 2.4 mg at 4-week intervals) to minimise gastrointestinal side effects and allow the body to adjust to the medication
Two different molecules, two different pathways, both converging on the goal of enhanced metabolic function
These strategies are worth pursuing if youre committed to brand-name medication, but for most people, compounded alternatives provide far more meaningful cost reduction